NEWS

Good News from NSFC! Four Group Alumni received NSFC Grants!

2024.8.23

On August 23, Dr. Qian Cheng, previously a PhD student in the RW group, currently Associate Professor at Chengdu University of Traditional Chinese Medicine; Dr. Xiaobei Huang, previously a postdoctoral fellow in the RW group, currently Associate Research Officer at Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences; Dr. Beibei Xie, previously a postdoctoral fellow in the RW group, Currently RAP at University of Macau; and Dr. Junyan Li, previously a PhD student in the RW group, currently a postdoctoral fellow at Zhejiang University, were all approved for NSFC Youth Funds. Congratulations! We are so proud of you all!!!

Ms. Xingping Quan passed her Ph.D. dissertation defense.

2024.4.18

On Apr 18th, our group member Xingaping Quan successfully passed her Ph.D. thesis oral defense. Congratulations to Dr. Quan graduate from RW Group. Wish all the best!

We are also grateful to Prof. Xianzheng Zhang from Wuhan University for his support in defense as external examiner.



Ms. Kwong Hei Ting (Cheryl) passed her Ph.D. dissertation defense.

2023.12.05

On Nov 13th, our group member Kwong Hei Ting (Cheryl) successfully passed her Ph.D. thesis oral defense. Congratulations to Dr. Kwong graduate from RW Group. Wish all the best!

We are also grateful to Prof. Shyh-Dar Li from University of British Columbia (Canada) for his support in defense as external examiner.

Joint Seminar of the University of Macau and Wuhan Institute of Virology(WIV),Chinese Academy of Sciences(CAS)

2023.11.16

On Nov 16th, Prof. Ruibing Wang’s group from the UM and Prof. Zhou Xi’s group from WIV of CAS jointly held the “Symposium on Cucurbit[n]uril-based nanocapsules antiviral drugs” in Wuhan,Hubei province. The participants had an active and in-depth exchange on their recent research achievements in antiviral drug area, and enthusiastic discussions on future friendly cooperation and academic visits.

Good News from NSFC!Two Group Members and One Group Alumni received NSFC General Program Grant and Youth Funds!

2023.8.28

On August 28, our current group member, Dr. Cheng Gao, research assistant professor in the RW Group, received approval  for his application of NSFC General Program Grant. Of note, Dr. Gao previously received NSFC youth fund.

In addition, Dr. Doudou Hu, a postdoctoral fellow in the RW group, and Dr. Yanlong Ma, our previous group alumnus (previously a PhD student in the RW group), currently lecturer at Guangzhou Pharmaceutical University, were both approved for their applications for NSFC Youth Fund. Congratulations! We are so proud of you all!!!

Great news! Ms. Huichao Zhao passed her M.Sc. dissertation defenses. Congrats!

2023.6.23

On June 21st, Ms. Huichao Zhao successfully passed M.Sc. dissertation defenses. Congratulations to Daisy! Daisy will go to Aarhus University in Denmark as a doctoral candidate for further study. Kudos to you!

 

Ms. Ziyi Wang won the Best Poster Award in 9th Macau Symposium on Biomedical Sciences!

2023.6.19

on June17th, after rigorous evaluation stages of peer expert review, award review committee and conference review, Ms. Ziyi Wang’s poster “Supramolecularly engineered platelets-hitchhiking delivery of morphology transformable peptide for Tumor Vascular Embolization” won the Best Poster Award in 9th Macau Symposium on Biomedical Sciences. Well done! Congratulations!

 

Enhancing targeted cancer therapy with supramolecular technology.

2023.5.19

A team of researchers at the University of Macau (UM) has developed an innovative technology that combines nanoparticles, bacterial membranes, and immune cells to deliver drugs directly to tumours to attack cancerous cells. Led by Wang Ruibing, a supramolecular chemist and associate professor at UM’s Institute of Chinese Medical Sciences (ICMS) and State Key Laboratory of Quality Research in Chinese Medicine, the team seeks to bring about more effective and personalised cancer treatments at a lower cost.

Supramolecular Smart Biomaterials Improve Targeted Drug Delivery

Since joining UM as a faculty member in 2014, Prof Wang has brought a wealth of experience in supramolecular chemistry, supramolecular biomaterials, radiopharmaceuticals, and molecular bioimaging to the university. Elected a fellow of the Royal Society of Chemistry in 2020, Prof Wang studies how molecules interact with each other and assemble themselves through non-covalent bonding, which creates simple yet smart structures with unique biological properties. He describes these structures, known as supramolecular molecules, as ‘molecules holding hands’. Through studying supramolecular chemistry, scientists have developed molecular structures for various needs, such as medicines and healthcare products.

Prof.Wang (centre) and his PhD students

Hunting Down Solid Tumour Tissue

According to Prof Wang, some anti-cancer drugs are often absorbed by non-cancerous tissues and cells before they reach their intended target, which can lead to unwanted side effects and provide limited therapeutic benefit to the patient.

To address this issue, scientists have developed various methods to deliver drugs and nanomedicines to tumours. One approach is to use the patient’s own cells that cancer tissues tend to attract. These cells are extracted from the patient’s body, modified or infused with drugs in a sterile environment, and then reintroduced into the body to help destroy cancer cells via targeted drug delivery. However, this method is often costly, time-consuming, and carries the risk of cell contamination outside the body. In search of a better solution, Prof Wang’s team has developed a technique that enables nanomedicines to ‘hitch a ride’ on macrophages in the body. In this way, nanomedicines can reach cancer cells by taking advantage of the innate ability of macrophages, which are a type of immune cells, to migrate to and accumulate in areas of inflammation in the body, a process known as inflammatory tropism. 

In essence, the team has developed a supramolecular nanomedicine that uses a macrocyclic compound called β-cyclodextrin (β-CD) as the host molecule and adamantane (Ada) as the guest molecule to modify, respectively, the surface of gold-nanoparticles (GNPs), which are used commonly in cancer therapy and diagnosis. 

To create the supramolecular nanomedicine, the researchers coated the β-CD-modified GNPs and the Ada-modified GNPs with the membrane of E. coli outer membrane vesicles. This membrane serves as a protective barrier that prevents the GNPs from prematurely interacting with each other via β-CD-Ada host-guest interactions before they are administered to a patient. In addition, the E. coli membrane coating makes this nanomedicine ‘bacteria-mimetic’. Once intravenously injected into the patient’s body, the E. coli-mimetic nanoparticles are engulfed by macrophages.

The membranes of E. coli are then broken down by lysosomal enzymes, paving the way for supramolecular assemblies of β-CD-modified and Ada-modified GNPs into supramolecular aggregates. These aggregates are formed via supramolecular host-guest interactions, also personified as ‘hands-holding’. ‘The cancer tissue is the destination, the macrophages are the transportation vehicles, and the supramolecular medicines are the hitchhikers. Without the vehicles, the hitchhikers alone may not efficiently reach their intended destination,’ says Prof Wang.

Photothermal Cancer Therapy

Inside the macrophages, the supramolecular aggregates of GNPs also gain a photothermal property via ‘plasmonic effects’ as a result of the close contact of the gold surface of these nanoparticles. This means that they heat up when exposed to light, which doctors can use to their advantage. They can direct a specific laser wavelength to the site of the tumour once sufficient nanomedicines have gathered in them. This treatment, known as photothermal therapy (PTT), generates high temperatures that destroy the cancer tissue and cells.

The research team tested the efficacy of the bacteria-mimetic nanomedicine by performing PTT on mice with melanoma, a type of skin cancer. The mice were divided into three groups. The first group received gold nanoparticles without E. coli outer membrane vesicles, the second group received gold nanoparticles coated with E. coli outer membrane vesicles, and the third group received a combination of GNPs coated with an E. coli membrane vesicle, with half of the GNPs modified with host molecules and the other half modified with guest molecules.

After injection of these formulations, the first group of mice showed minimal accumulation of GNPs in the tumour, the second group exhibited improved accumulation due to the macrophage-hitchhiking driven by bacteria-mimics, while the third group showed a significant amount of GNPs deposited in the tumour, attributed to the intracellular supramolecular aggregation of GNPs that minimised premature loss during macrophage-hitchhiking delivery. When irradiated with laser, the solid tumour tissue in the third group of mice reached a very high temperature, yet no visible damage was found in the surrounding tissues apart from the tumour. This again indicates that most of the supramolecular nanomedicine had reached its intended target, the tumour tissue. Conversely, the tumour sites of the two other groups of mice showed a very modest temperature increase. Accordingly, when combined with anti-PD-L1, an immune checkpoint inhibitor, the bacteria-mimetic supramolecular nanomedicine exhibited the best therapeutic effect against melanoma, by having nearly eliminated all tumours from mice.  

Towards Validation and Development

In 2022, the leading journal Science Advances published the team’s paper, titled ‘In vivo Hitchhiking of Immune Cells by Intracellular Self-assembly of Bacteria-mimetic Nanomedicine for Targeted Therapy of Melanoma.’ Prof Wang is the lead corresponding author and Simon Lee, distinguished professor in the ICMS, is the co-corresponding author. Postdoctoral fellow Gao Cheng and master’s student Wang Qingfu are the co-first authors. UM PhD students Li Junyan and Cheryl Kuong, research assistant Wei Jianwen, and postdoctoral fellow Xie Beibei also made important contributions to this research project. The project was funded by the Dr Stanley Ho Medical Development Foundation, the Macao Special Administrative Region Science and Technology Development Fund, the National Natural Science Foundation of China, and the Ministry of Education Frontiers Science Center for Precision Oncology at UM.

The research project was showcased in the 2022 Guangdong-Hong Kong-Macao Greater Bay Area High-value Patent Portfolio Layout Competition and received a silver medal, as one of only 25 gold and silver awardees, surpassing thousands of other entries. This success has drawn the attention of several companies in mainland China, which have expressed interest in partnering with the team to further develop and test the efficacy and safety of this innovative method.

Prof.Wang’s research team was awarded a silver medal at the 2022 Guangdong-HongKong-Macao Greater Bay Area High-value Patent Portfolio Layout Competition

Supramolecular Technology: A Versatile Tool to Improve Disease Therapies

Prof Wang’s team has conducted cutting-edge studies on the application of supramolecular technology for smart drug delivery in recent years, and this new method of cancer drug delivery is just one example. Another focus of the team is to combat acute pneumonia by enhancing drug delivery to the inflammatory lungs. To achieve this, the team has developed a technique that enables drugs to hitch a ride on red blood cells through a supramolecular interaction between β-cyclodextrin anchored on the cells, and ferrocene anchored on the surface of nanomedicine. ‘Red blood cells are biocompatible and have a long circulation time in the body, which makes them ideal carriers for drugs that need sustainable delivery.’ says Prof Wang. The team has found that curcumin, when delivered in this way, provides an effective treatment for acute pneumonia in mice.

Supramolecular technology also has the potential to control bleeding both inside and outside the body, which is a major threat to human life during surgery or after trauma. One way to tackle this issue is to inject plasma containing a lot of platelets, but they may not always reach the site of bleeding quickly. To enhance the platelets’ ability to target and clot injured blood vessels, Prof Wang’s team has used supramolecular interactions between cucurbit[7]uril (CB[7]), a type of macrocyclic molecule, and other compounds to modify platelets, turning them into ‘supramolecularly functionalised platelets’. In experiments with mice, the supramolecularly engineered platelets were found to greatly reduce the time and volume of bleeding compared to using normal platelets.

Supramolecular chemistry is a fascinating field that studies non-covalent bonding between molecules, from electrostatic interactions to hydrophobic effects. Research results in the field have already been translated into many everyday products and have great potential for the future. ‘Continued research into supramolecular systems will enable the design of increasingly smart structures that serve even more biomedical applications,’ says Prof Wang. ‘Tiny supramolecules have the potential to solve big problems for humanity, not just through drug delivery, but by unlocking an endless stream of ideas and solutions.’

 

Ms. Xun Xu, Mr. Yuanfu Ding, Ms. Qian Cheng, Ms. Junyan Li and Ms. Meng Xu passed their Ph.D. dissertation defense.

2023.4.28

On Apr 27th and Apr 28th, our group members: Xun xu, Yuanfu Ding, Qian Cheng, Junyan Li and Meng Xu successfully passed their Ph.D. thesis oral defense respectively. Congratulations to Dr. Xu, Dr. Ding, Dr. Cheng, Dr. Li and Dr. Xu graduate from RW Group. Wish their all the best!

We are also grateful to Prof. Ping Gong from Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences (China), Prof. Yanli Zhao from Nanyang Technological University (Singapore), Prof. Jianxiang Zhang from Department of Pharmacy and Laboratory Medicine, Army Medical University for their support in defense as external examiner.

 

group members won Silver Award in the final of the Guangdong-Hong Kong-Macao Greater Bay Area High-Value Patent Training Layout Competition in 2022(湾高赛)!

2023.2.10

On Feb 10th, after intense competition and the evaluation from five dimensions of the project market, cultivation layout, commercial value realization, patent operation, and asset evaluation by review expert, our project ‘Supramolecular cell kit for live cell drug delivery’ won the Silver Award in the final of the Guangdong-Hong Kong-Macao Greater Bay Area High-Value Patent Training Layout Competition in 2022! Warm congratulations to our members for their hard work on the project! Miss Wei went to Foshan to accept the award as a team representative and was interviewed by the media.

 

Joint online Seminar of the University of Macau and Nanjing University

2022.12.10

On Dec 10th, the joint online seminar for teachers and students of the universities of Macau and Nanjing university was held smoothly. The participants had an active and in-depth exchange on their recent research achievements in supramolecular chemistry and biomaterials, and enthusiastic discussions on future friendly cooperation and academic visits.


Prof. Wang and Dr. Gao won The Second prize in Science and Technology Award of Macao Special Administrative Region!

2022.11.16

On November 11th, after rigorous evaluation stages of peer expert review, initial evaluation by award review committee and conference review, our project “Supramolecular cell-based drug delivery system for targeted therapy of inflammatory disease and cancer” was awarded the Second prize of Science and Technology Award of Macao Special Administrative Region in recognition of its contribution to the development of technological innovation in Macao.

RW group members won the Graduate Science and Technology Research and Development Award of Macao Special Administrative Region!

2022.11.16

On November 11th, Ziyi Wang was awarded the Graduate Science and Technology Research and Development Award for Master Students of Macao Special Administrative Region. And Dr. Chen Sun was awarded the Graduate Science and Technology Research and Development Award for Ph.D Students of Macao Special Administrative Region. Well done!Congratulations!

 

Ms. Qiaoxian Huang passed her Ph.D. dissertation defense.

2022.9.23

On Sep 23st, Qiaoxian Huang successfully passed her Ph.D. dissertation defense.  Congratulations to Dr. Huang! Dr. Qiaoxian Huang is the eighth Ph.D. graduate from RW Group.  Wish her all the best!

We are also grateful to Prof. Jingming Zhang from Chengdu University of TCM for his support of Qiaoxian’s Ph.D. defense online!

Good News from NSFC! Two Group Alumni received NSFC Youth Funds!

2022.9.8

On September 8th, Two group Alumni, Dr. Chen Sun, Associate Professor at Hainan University, and Dr. Kuikun Yang, Full Professor at Harbin Institute of Technology, received approval letters for their applications for NSFC Youth Fund. Notably, this is their very first application for such a highly competitive grant! In addition to these two, RW group alumni Dr. Cheng Gao, Research Assistant Professor at UM, Dr. Xiangjun Zhang, Associate Professor at Chongqing Medical University, and Dr. Shuwen Guo, Associate Professor at Shaanxi Normal University, received NSFC Youth Fund last year (2021), also during their first efforts of applying for such grants. Congratulations! We are so proud of you all!!!

Meanwhile, RW received NSFC General Program grant this year, marking the group’s third NSFC general program grant since joining UM. 

RW group members won the Grand Prize in the “Guangdong Maker” (创客广东)!

2022.7.12

On July 12, after one month of fierce competition, the entrepreneurial team composed of Ms. Jianwen Wei, Ms. Ziyi Wang, and Ms. Qian Cheng, led by Prof. R. Wang, successfully won “the Grant Prize Award“ for their excellent performance in promoting our supramolecular cell technology platform for potential translation. Ms. Wang Ziyi presented a wonderful product introduction as a key speaker. 

Shortly after, the team won the Second Prize in the final race, competing with numerous mid and small businesses and university entrepreneurship teams!

RW group members won the First Prize in the “One Million Dollar Macau Regional Entrepreneurship Competition”!

2022.4.28

On April 28st, after the fierce competition, the entrepreneurial team composed of Ms. Jianwen Wei, Ms. Ziyi Wang, Mr. Cheng Gao, and Ms. Qian Cheng, led by Prof. R. Wang, successfully won “the First Prize Award’ for their excellent performance in promoting our supramolecular cell technology platform for potential translation. Meanwhile, the team won 50,000 MOP as a cash prize. Looking forward to further development of our star product “Supracell Kit”! 


Our recent paper published by Nano Today was highlighted by the wechat channel of Frontiers of Polymer Science

2022.1.25

On Jan 25st, Frontiers of Polymer Science highlighted our new work. This paper titled “Efficient Intracellular Delivery of Native Proteins Facilitated by Preorganized Guanidiniums on Pillar[5]arene Skeleton” by Shuwen Guo et al was recently published in Nano Today.

Our recent paper published by Mater. Horiz. was highlighted by the wechat channel of Frontiers of Polymer Science 

2022.01.21

On Jan 21st, Frontiers of Polymer Science highlighted our new work. This paper titled “Enhanced antibacterial function of a supramolecular artificial receptor-modified macrophage (SAR-Macrophage)” by Qian Cheng et al was published in Materials Horizons and was featured as a front cover article.

Prof. Ruibing Wang was invited by the School of Chemistry and Chemical Engineering, Nanjing University for the “Distinguished Scholar Forum”.

2021.12.16

On December 16th, Prof. Wang was invited by the school of Chemistry and Chemical Engineering, Nanjing University, and delivered a talk at the” Distinguished Scholar Forum”(名師講壇)  to the professors and students, with the seminar title of “Design and Preparation of Supramolecular Biomaterials for the Treatment of Inflammatory Disease and Cancer”.


Great news! Ms. Mingju Shui passed her M.Sc. dissertation defenses. Congrats!

2021.12.09

On December 9th, Ms. Mingju Shui successfully passed M.Sc. dissertation defenses,. Congratulations to Mingju! Mingju will stay in the ICMS as a doctoral candidate for further study. Kudos to you!

Our recent paper published by Nanoscale Horizons was highlighted by Mat+ 

2021.11.11

On Nov 11st, Mat+ introduce our new work. This paper titled “Macrophage-hitchhiking supramolecular aggregates of CuS nanoparticles for enhanced tumor deposition and photothermal therapy” by Junyan Li et al was published in Nanoscale Horizons and was featured as an inside cover article.

 

Ms. Ludan Yue passed her Ph.D. dissertation defense.

2021.11.01

On Nov 1st, Ludan Yue successfully passed her Ph.D. dissertation defense.  Congratulations to Dr. Yue! Dr.Ludan Yue is the seventh Ph.D. graduate from RW Group.  Wish her all the best!

We are also grateful to Prof. Qingzheng Yang from Beijing Normal University for his support of Ludan’s Ph.D. defense online!

Great news! Ms. Ziyi Wang and Ms. Zeyu Wang passed their M.Sc. dissertation defenses, respectively. Congrats!

2021.06.19

On June 19th, Ms. Ziyi Wang and Ms. Zeyu Wang successfully passed M.Sc. dissertation defenses, respectively. Congratulations to ZIyi and Zeyu! Both of them will stay in the RW group as doctoral candidates to go further study. Kudos to you both!

 

Mr. Chen Sun passed his Ph.D. dissertation defense.

2021.06.03

On June 3rd, Chen Sun successfully passed his Ph.D. dissertation defense.  Congratulations to Dr. Sun! Dr. Chen Sun is the sixth Ph.D. graduate from RW Group.  Wish him all the best!

We are also grateful to Prof. Jiangfei Xu from Tsinghua University for his support to Chen Sun’s Ph.D. defense!

RW group member won prizes in the “One Million Dollar Macau Regional Entrepreneurship Competition”

2021.05.06

On May 5th, After the fierce competition, the entrepreneurial team composed of  Ms. Zeyu Wang, Ms. Jianwen Wei, Ms. Zhiqing Yang, Mr. Cheng Gao, and Mr. Yuanfu Ding successfully won “the Best Exhibition Award’ for their excellent performance. Looking forward to the team’s wonderful performance next time!

 

Mr. Yan-long Ma passed his Ph.D. dissertation defense.

2021.03.04

On March 4th, Mr. Yan-long Ma successfully passed his Ph.D. dissertation defense.  Congratulations to Dr. Ma! Wish him all the best!

We are also grateful to Prof. Wei Jiang as Mr. Ma’s co-supervisor  from Southern University of Science and Technology and Prof. Dongsheng Guo from Nankai University for their support to Yan-ling’s PhD defense online!

 

Ms. Qian Cheng received an award at a recent international conference Biomaterials2020

2020.11.15

Ms. Qian Cheng won the Best Poster Award from “Biomaterials 2020 ”(海峡两岸暨港澳生物材料与组织再生青年科学家学术会议) in Shanghai. Way to go, Qian!

 

Prof. Ruibing Wang elected as Fellow of the Royal Society of Chemistry!

2020.11.12

In Nov. 2020, Prof. R Wang was elected as a fellow of the Royal Society of Chemistry (FRSC) in the United Kingdom. Founded in 1841, RSC (www.rsc.org) is the oldest chemical society in the world, with more than 54,000 members and 1,700 fellows (including around 75 Nobel Laureates). Each year up to 52 Fellows and up to 10 Foreign Members are elected from a group of around 800 candidates who are proposed by the existing Fellowship. Achieving fellow status in the chemical profession denotes to a high level of accomplishment as a professional chemist. Kudos to RW!

Mr. Xiangjun Zhang passed his Ph.D. dissertation defense.

2020.11.10

On November 10th, Mr. Xiangjun Zhang successfully passed his Ph.D. dissertation defense.  Congratulations to Dr. Zhang! Dr. Zhang will join Chongqing Medical University as a Principal Investigator to further develop his research career. Wish him all the best!

We are also grateful to Prof. Jianxiang Zhang from the Third Military Medical University for his their support to Xiangjun’s PhD defense online!

 

Prof. Ruibing Wang and Dr. Cheng Gao won the Macau Science and Technology Award 2020. Congrats!

2020.10.07

On Oct. 7th, the Macao SAR government presented the Macao Science and Technology Awards 2020. A research team led by Prof. Ruibing Wang, joined by Prof. Simon Lee and Dr. Cheng Gao, received the third prize in the Technological Invention Award category. What an exciting night!

 

Miss. Qian Cheng became the third member of RW group to win the Macau Postgraduate Science and Technology Research Award. Congrats!

2020.10.07

On the same day, Miss. Qian Cheng, a former MSc student and currently a PhD candidate from RW group, received the Scientific and Technological R&D Award for Postgraduates for her excellent research work conducted during her MSc studies! Bravo!

 

Great news! Mr. Tianlei Sun and Ms. Jianwen Wei passed their Ph.D. and M.Sc. dissertation defenses, respectively. Congrats!

2020.08.10

On August 10th, Mr. Tianlei Sun and Ms. Jianwen Wei successfully passed Ph.D. and M.Sc. dissertation defenses, respectively. Congratulations to Dr. Sun and Jianwen! Jianwen will stay in the RW group as a Research Assistant to provide all-around support. Dr. Sun will return to Yangtze River delta area for his future career development in industry. Kudos to you both!

 

Ms. Kwong Hei Ting Cheryl passed her MSc dissertation defense.

2020.07.01

On July 1st, Ms. Kwong Hei Ting Cheryl passed her M.Sc. dissertation defense. Congratulations, Cheryl ! Way to go! Cheryl will stay in the RW group (co-supervised by Prof. Simon Lee) as a PhD student. Look forward to more of your excellent work!

 

The first “non-virtual” group meeting during the pandemic was held successfully

2020.06.08

In the very first offline group meeting during the pandemic, members spoke freely and actively participated in the discussion in literature sharing and project progress report. Thank God, everyone is safe, happy and healthy!

 

Prof. Feihe Huang research group visited us

2019.12.13

Prof. Feihe Huang and his research group from the University of Zhejiang visited us and had a joint UM-ZJU group meeting. Members from both groups enjoyed the exchange of ideas and learning experiences!

 

 

Ms. Cheryl and Ms. Amy both received awards at the recent international conference

2019.12.12

Ms. Cheryl and Ms. Amy won the best poster award from “The 20th General Assembly of the Federation of Asian Chemistry Societies and The 18st Asian Chemistry Congress ”(第20届亚洲化学学会联合会大会和第18届亚洲化学大会) in Taipei, ROC. Congratulations, Cheryl and Amy !

 

 

Mr. Cheng Gao passed his Ph.D. dissertation defense.

2019.11.05

On November 5th, Mr. Cheng Gao successfully passed his Ph.D. dissertation defense.  Congratulations to Dr. Gao ! Dr. Gao will stay in the RW group as a distinguished UM Macao Postdoctoral Fellow to continue his journey in supramolecular biomimetic drug delivery.

We are also grateful to Prof. Yanli Zhao from NTU and Prof. Yu Han from KAUST for their wonderful talks and their support to Cheng’s defense!

 

 

UM Teaching Excellence Award recipient gives talk on connecting classrooms to reality

2019.09.23

The University of Macau (UM) today (23 September) held the UM Teaching Excellence Award Seminar. Associate Professor Wang Ruibing from the Institute of Chinese Medical Sciences, who is the recipient of the UM Teaching Excellence Award for the 2018/2019 academic year, gave a talk titled ‘Connecting Classrooms to Reality’. The talk attracted many UM faculty members, students, high school teachers and students, as well as members of the general public.

 

Ms. Ludan Yue and Ms. Jianwen Wei  received awards at the recent international conference

2019.08.19

Ms. Ludan Yue and Ms. Jianwen Wei  won the best poster award from “The 8th International Conference on Nanoscience & Technology,China 2019”(第8届国际纳米科学与技术会议,中国2019年) organized in Beijing China. Congratulations !


Ms. Qian Cheng passed her MSc dissertation defense.

2019.05.31

On On May 31th, Ms. Qian cheng passed his M.D. dissertation defense.
Congratulations, Qian ! Way to go! Qian will stay in the RW group as a Research Assistant, continuing her adventure in supramolecular biomaterials.